Position in SCLX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$260,331
+$217,256 QoQ
Shares Held
33,531
+222.8% QoQ
Ownership
0.395%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 72 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UBS Group AG holds $17,056,271,930 across 20 Drug Manufacturers - General names. SCLX ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,865,931 | $4,636,914,000 | |
| 2 | ABBV |
AbbVie Inc.
|
12,845,120 | $3,232,345,993 | |
| 3 | JNJ |
Johnson & Johnson
|
11,036,891 | $2,803,039,201 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,744,783 | $1,766,204,613 | |
| 5 | AMGN |
Amgen Inc
|
3,308,695 | $1,198,144,628 | |
| 6 | AZN |
Astrazeneca PLC
|
5,297,462 | $1,004,504,738 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,503,294 | $568,946,162 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,876,439 | $511,460,413 |
All Filings in SCLX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $260,331 | 33,376 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $43,075 | 6,468 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $144,018 | 11,805 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $504,788 | 25,650 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $108,527 | 18,426 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $182,150 | 731,541 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $41,462 | 97,335 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,559 | 3,849 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,128 | 1,621 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,527 | 7,250 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $62,707 | 30,739 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $16,322 | 11,659 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,498,763 | 269,078 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $113,512 | 13,843 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $29,027 | 7,275 | Shares | Sole | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||